The University of North Carolina at Chapel Hill has established a research training program in Hematology/Oncology for M.D., M.D./Ph.D., and Ph.D. postdoctoral fellows that extends across disciplines to offer trainees an in- depth research experience in clinical or basic research. The objective of the program is to prepare trainees for independent academic careers in areas that are directly relevant to disorders of the blood, vasculature, or the immune system. Training is offered in the specific areas of Hemostasis, Thrombosis and Vascular Biology, Hematopoiesis/Sickle Cell Anemia, Immunology, Virology, and the Molecular Basis of Neoplasia. Faculty mentors have been selected for the program based on programmatic relevance and training records, as well as research quality and funding. A dramatic expansion of the Hematology/Oncology Program in the past five years has brought to the program several outstanding young faculty with expanding research programs who will be able to serve as mentors during the next granting period. The training environment is further supported by a number of outstanding Centers, including the Center for Hemostasis and Thrombosis and the Lineberger Comprehensive Cancer Center, as well as by excellent basic science departments. A large number of superb core facilities will allow trainees the opportunity to learn new technologies in well-supervised settings. Dr. Beverly Mitchell, the P.I. of the grant, has strong interest and experience in the mentoring of trainees. She will function in association with Dr. Harold Roberts and an Advisory Committee in the selection of trainees and in the direct supervision of their training program and career development. Trainees will have the opportunity to attend a wide variety of research and teaching conferences and to present in both small and large groups. They will spend 90-100 percent of their time in research during the time on the training grant. Progress will be reviewed by the Advisory Committee and all trainees will be encouraged to submit grant applications to extend their research training during the first or second year on the training grant. Additional training opportunities will be available through courses sponsored by the General Clinical Research Center and Carolina Workshops sponsored by the North Carolina Program in Molecular Biology and Biotechnology. Based on the superb research environment and the commitment of the P.I. to the development of well-trained clinical and basic scientists in the area of Blood Diseases, the program has attracted a steadily increasing number of outstanding applicants. We thus request six post-doctoral fellow positions for the next five years of this grant.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL007149-26
Application #
6313714
Study Section
Special Emphasis Panel (ZHL1-CSR-M (F1))
Program Officer
Mondoro, Traci
Project Start
1975-07-01
Project End
2006-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
26
Fiscal Year
2001
Total Cost
$306,738
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Klein, Mia; Chang, Alicia K; Vasudevan, Sanjeev A et al. (2018) Clinically significant ascites as an indication for resection of rapidly involuting congenital hepatic hemangiomas. Pediatr Blood Cancer 65:e27222
Beckman, Joan D; Rollins-Raval, Marian A; Raval, Jay S et al. (2018) Bortezomib for Refractory Immune-Mediated Thrombocytopenia Purpura. Am J Ther 25:e270-e272
Beckman, J D; Holle, L A; Wolberg, A S (2018) Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin ?-chain crosslinking. J Thromb Haemost 16:131-141
Hisada, Yohei; Mackman, Nigel (2018) Mouse models of cancer-associated thrombosis. Thromb Res 164 Suppl 1:S48-S53
Pahl, Kristy S; Kim, Kyung; Sams, Casey et al. (2018) Inconsistency in classifying vascular anomalies: What's in a name? Pediatr Blood Cancer 65:
Hisada, Yohei; Thålin, Charlotte; Lundström, Staffan et al. (2018) Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients. Thromb Res 165:1-5
Beckman, Joan D; Kasthuri, Raj S; Wolberg, Alisa S et al. (2018) Challenges in diagnosis and management of acquired factor XIII (FXIII) inhibitors. Haemophilia 24:e417-e420
Houghton, Damon E; Moll, Stephan (2017) Antiphospholipid antibodies. Vasc Med 22:545-550
Martin, Karlyn A; Lee, Craig R; Farrell, Timothy M et al. (2017) Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. Am J Med 130:517-524
Houghton, Damon E; Sud, Shivani; Moll, Stephan et al. (2017) Perils in the thrombophilia workup: Frequency and circumstances of erroneously ordered factor V activity tests for thrombophilia. Vasc Med 22:527-528

Showing the most recent 10 out of 72 publications